title: Case report of Klinefelter's syndrome with severe diabetes, dyslipidemia, and stroke: The effect of pioglitazone and other anti-inflammatory agents on interleukin-6 and -8, tumor necrosis factor-alpha, and C-reactive protein.
authors.forename: Issei
authors.initials: I
authors.lastname: Yoshiuchi
authors.forename: Naoto
authors.initials: N
authors.lastname: Itoh
authors.forename: Misa
authors.initials: M
authors.lastname: Nakano
authors.forename: Chikao
authors.initials: C
authors.lastname: Tatsumi
authors.forename: Kenji
authors.initials: K
authors.lastname: Yokoyama
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Matsuyama
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D007713:Klinefelter Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D000077205:Pioglitazone; D020521:Stroke / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D000893:Anti-Inflammatory Agents; D015850:Interleukin-6; D016209:Interleukin-8; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein; D000077205:Pioglitazone